Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Biovie Inc (BIVI)

Biovie Inc (BIVI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.7800 +0.0393 (+5.31%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.7800 unch (unch) 19:09 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.7371
Day High
0.7937
Open 0.7400
Previous Close 0.7407 0.7407
Volume 67,700 67,700
Avg Vol 240,180 240,180
Stochastic %K 25.61% 25.61%
Weighted Alpha -83.98 -83.98
5-Day Change +0.0050 (+0.65%) +0.0050 (+0.65%)
52-Week Range 0.6200 - 7.5000 0.6200 - 7.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,393
  • Shares Outstanding, K 18,452
  • Annual Sales, $ 0 K
  • Annual Income, $ -32,120 K
  • EBIT $ -24 M
  • EBITDA $ -23 M
  • 60-Month Beta 0.64
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.55
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -9.76
  • Most Recent Earnings $-0.46 on 02/11/25
  • Next Earnings Date 05/13/25
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.32
  • Number of Estimates 1
  • High Estimate -0.32
  • Low Estimate -0.32
  • Prior Year -2.00
  • Growth Rate Est. (year over year) +84.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6200 +25.81%
on 04/07/25
Period Open: 1.0450
1.2471 -37.45%
on 03/21/25
-0.2650 (-25.36%)
since 03/11/25
3-Month
0.6200 +25.81%
on 04/07/25
Period Open: 2.2100
2.2900 -65.94%
on 01/21/25
-1.4300 (-64.71%)
since 01/10/25
52-Week
0.6200 +25.81%
on 04/07/25
Period Open: 4.9530
7.5000 -89.60%
on 10/21/24
-4.1730 (-84.25%)
since 04/11/24

Most Recent Stories

More News
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New to The Street debuts its inaugural restaurant segment featuring BlackBarn with owner and chef John Doherty

RDZN : 1.3100 (+14.91%)
HIT : 0.7000 (+8.46%)
PETV : 0.5000 (-8.26%)
ACXP : 0.3543 (+5.60%)
BIVI : 0.7800 (+5.31%)
SGTM : 0.0770 (+2.67%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice President

BlackBarn Restaurant NYC on 26th street The premiere restaurant segment with Owner and Head Chef John Doherty

RDZN : 1.3100 (+14.91%)
HIT : 0.7000 (+8.46%)
PETV : 0.5000 (-8.26%)
ACXP : 0.3543 (+5.60%)
BIVI : 0.7800 (+5.31%)
SGTM : 0.0770 (+2.67%)
New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice

New Segment "Market Bites" Debuts with Chef John Doherty of BlackBarn Showcasing the Culinary Side of Business Leadership

RDZN : 1.3100 (+14.91%)
PETV : 0.5000 (-8.26%)
ACXP : 0.3543 (+5.60%)
BIVI : 0.7800 (+5.31%)
SGTM : 0.0770 (+2.67%)
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.

Sponsored by The Sustainable Green Team (OTC: SGTM), featuring Kevin Harrington - the ORIGINAL Shark from Shark Tank

RDZN : 1.3100 (+14.91%)
BIVI : 0.7800 (+5.31%)
TNXP : 16.88 (-2.43%)
SGTM : 0.0770 (+2.67%)
BioVie to Host KOL Investor Webcast to Discuss the Long COVID Treatment Landscape and its ADDRESS-LC Trial on April 10, 2025

BIVI : 0.7800 (+5.31%)
New to The Street’s FOX Business Show #638 Spotlights Visionary CEOs and Breakthrough Innovations Across Health, AI, and Insurance Featuring BioVie CEO Cuong Do, Roadzen CEO Rohan Malhotra, Lou Basenese’s The Big Skinny on eXoZymes, and Banzai CEO Joe

Sponsored by The Sustainable Green Team and Featuring an Exclusive Interview with Former Shark Kevin Harrington

RDZN : 1.3100 (+14.91%)
BNZI : 1.0300 (+0.98%)
BIVI : 0.7800 (+5.31%)
SGTM : 0.0770 (+2.67%)
New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)

The Sustainable Green Team ($SGTM), with Kevin Harrington, "Original Shark Tank" Investor, and CEO Tony Raynor, Features Sponsor with Full Interview Link. Plus, the Debut of the New Roadzen $RDZN TV Commercial...

PETV : 0.5000 (-8.26%)
BNZI : 1.0300 (+0.98%)
BIVI : 0.7800 (+5.31%)
SGTM : 0.0770 (+2.67%)
ZAPP : 0.5947 (-0.67%)
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

Also Featuring The Sustainable Green Team ($SGTM) with Shark Tank's Kevin Harrington Showcasing Their WaterLess Garden Product

RDZN : 1.3100 (+14.91%)
BIVI : 0.7800 (+5.31%)
ATCH : 0.5288 (-1.53%)
EXOZ : 10.90 (-7.39%)
New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM)

NEW YORK, NY / ACCESS Newswire / February 22, 2025 / New to The Street is set to deliver an engaging broadcast on Bloomberg Television this evening at 6:30 PM EST as sponsored programming. The show will...

RDZN : 1.3100 (+14.91%)
BIVI : 0.7800 (+5.31%)
BioVie Inc. ($BIVI) Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, and Exclusive Accredited Events

NEW YORK, NY / ACCESSWIRE / January 13, 2025 / New to The Street, a leading FMW Media production, is thrilled to announce its partnership with BioVie Inc. (NASDAQ:BIVI), a clinical-stage biopharmaceutical...

BIVI : 0.7800 (+5.31%)

Business Summary

BioVie Inc. engages in developing drug therapies for liver disease. The company's product candidate includes BIV201, which are in clinical stage. BioVie Inc. is based in SANTA MONICA, CA.

See More

Key Turning Points

3rd Resistance Point 0.8600
2nd Resistance Point 0.8269
1st Resistance Point 0.8034
Last Price 0.7800
1st Support Level 0.7468
2nd Support Level 0.7137
3rd Support Level 0.6902

See More

52-Week High 7.5000
Fibonacci 61.8% 4.8718
Fibonacci 50% 4.0600
Fibonacci 38.2% 3.2482
Last Price 0.7800
52-Week Low 0.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar